Guided Internet-delivered Cognitive-behavioral Therapy for Former Chronic Pain Patients
- Conditions
- Chronic Pain
- Interventions
- Behavioral: Guided Internet-based cognitive behavioural treatment
- Registration Number
- NCT01491269
- Lead Sponsor
- Gerhard Andersson
- Brief Summary
The aim of the present study was to investigate if guided Internet-delivered Cognitive-behavioral Therapy (CBT) would help chronic pain patients who had previously undergone a multidisciplinary treatment but still have residual problems.
- Detailed Description
The present study investigates Internet-delivered CBT as a tertiary intervention. This is motivated by the fact that many pain patients relapse after rehabilitation and some may be in need of additional treatment. The persons who fulfills the inclusion criteria undergoes a structured telephone interview. The study is a experimental design with a treatment and an active control group measured before and after a treatment period. The control group were invited to participate in a moderated online discussion forum. Follow up data was collected six months after the treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
- to have been medically investigated (within one year)
- completed the multidisciplinary rehabilitation program
- have residual symptoms after the rehabilitation treatment (defined as functional impairment caused by their pain)
- have Internet access
- planned surgery
- ongoing medical investigation that could impede participation in the study
- suffering from acute physical or psychological conditions
- people confined to wheelchairs
- people not fluent with the Swedish language
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Internet delivered CBT Guided Internet-based cognitive behavioural treatment Internet delivered cognitive behavioral intervention, 8 weeks treatment.
- Primary Outcome Measures
Name Time Method The Coping Strategies Questionnaire (CSQ) One week pre treatment, one week post treatment The CSQ contains 50 items divided in eight scales that measures different cognitive and behavioral coping strategies. The different coping strategies are: diverting attention, re-interpreting pain sensations, coping self-statements, ignoring sensations, praying and hoping, catastrophizing, increased behavioral activities and pain behavior (Rosenthiel \& Keefe, 1983). Change from baseline in the different subscales pre- and post treatment.
- Secondary Outcome Measures
Name Time Method Quality of Life Inventory (QOLI) One week pre treatment, one week post after treatment QOLI contains 32 items for assessing life satisfaction. The assessment yields an overall score and profile in 16 areas of life; health, self-esteem, goals and values, money, work, play, learning, creativity, helping, love, friends, children, relatives, home, neighborhood and community. Each item is rated in terms of importance and satisfaction.
Chronic Pain Acceptance Questionnaire (CPAQ) One week pre treatment, one week post treatment CPAQ contains 20 items divided in two scales, engagement and willingness. CPAQ measures acceptance in relation to chronic pain.
Multidimensional Pain Inventory, MPI One week pre treatment, one week post treatment MPI, assess psychosocial and behavioural consequences of pain. It´s divided into 2 sections and consisting of 8 scales. These are: Pain Severity, Interference, Life Control, Affective Distress, Support, Punishing Responses, Solicitous Responses and Distracting Responses.
Pain and Impairment Relationship Scale (PAIRS) One week pre treatment, one week post treatment PAIRS consist of 15 personal statements that reflect thoughts, attitudes and opinions about pain. The questionnaire assesses beliefs and attitudes that patients have regarding pain and ability to function despite discomfort.
Hospital Anxiety and Depression Scale, HADS One week pre treatment, one week post treatment HADS is a 14-item questionnaire, and is designed to measure anxiety and depression in non-psychiatric patients.
Trial Locations
- Locations (1)
Uppsala University
🇸🇪Uppsala, Sweden